Shares of Ingevity Corporation (NYSE:NGVT – Get Free Report) have been given an average rating of “Hold” by the five research firms that are covering the firm, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $80.00.
Several brokerages have recently commented on NGVT. Weiss Ratings downgraded Ingevity from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, October 23rd. Wall Street Zen cut Ingevity from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 1st.
Read Our Latest Report on Ingevity
Insider Buying and Selling
In other Ingevity news, CEO David Li sold 5,000 shares of the firm’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $75.83, for a total value of $379,150.00. Following the completion of the transaction, the chief executive officer directly owned 120,636 shares in the company, valued at $9,147,827.88. This trade represents a 3.98% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 15,092 shares of company stock worth $1,147,773 over the last ninety days. 0.88% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On Ingevity
Large investors have recently made changes to their positions in the company. Vise Technologies Inc. purchased a new position in Ingevity during the 3rd quarter worth approximately $278,000. VestGen Advisors LLC purchased a new stake in shares of Ingevity in the third quarter valued at $209,000. Simplicity Wealth LLC lifted its holdings in shares of Ingevity by 108.8% in the third quarter. Simplicity Wealth LLC now owns 6,572 shares of the company’s stock valued at $465,000 after purchasing an additional 3,424 shares in the last quarter. Fifth Third Wealth Advisors LLC acquired a new stake in shares of Ingevity in the third quarter worth $818,000. Finally, Axxcess Wealth Management LLC acquired a new stake in shares of Ingevity in the third quarter worth $371,000. Institutional investors and hedge funds own 91.59% of the company’s stock.
Ingevity Stock Performance
Shares of NYSE NGVT opened at $73.82 on Tuesday. The company has a quick ratio of 1.15, a current ratio of 1.61 and a debt-to-equity ratio of 22.52. The stock has a market capitalization of $2.54 billion, a price-to-earnings ratio of 50.22 and a beta of 1.14. The stock’s fifty day simple moving average is $70.51 and its 200 day simple moving average is $71.21. Ingevity has a 52-week low of $45.85 and a 52-week high of $79.29.
Ingevity Company Profile
Ingevity Corporation (NYSE: NGVT) is a specialty chemicals and materials company that develops products designed to improve performance, efficiency, and sustainability across a range of industrial and consumer applications. Its offerings serve markets including automotive, transportation, agriculture, coatings, adhesives, pavement markings, and industrial manufacturing.
The company is best known for activated carbon products used in automotive vapor-emission control systems, where they help capture fuel vapors and reduce emissions.
Featured Stories
- Five stocks we like better than Ingevity
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AIāThese 5 Stocks Are Getting Paid
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.
